Pharma stocks in India experienced significant gains on Monday, with some shares rising as much as 20%, despite a broader market downturn. The Nifty Pharma index increased by 1.65%, driven by strong buying momentum across the sector. Torrent Pharmaceuticals and Mankind Pharma led the gains, each rising over 3%.
Key Details
Cipla, Divi’s Laboratories, Laurus Labs, Alkem Laboratories, and Sai Life Sciences saw their shares rise by more than 2%. Other notable performers included Zydus Lifesciences, Aurobindo Pharma, and Ajanta Pharma, which recorded gains of over 1%. Additionally, Tatva Chintan Pharma Chem's share price surged 20% to a new 52-week high of ₹1,714.10 following strong first-quarter results.
Background
This rally in pharma stocks occurred amid a broader decline in the Indian stock market, with the BSE Sensex down 671.29 points, or 0.86%, at 77,480.16, and the NSE Nifty 50 falling 169.40 points, or 0.70%, to 24,164.75. The overall market sentiment was affected by a decline in global markets, driven by concerns over the escalating US-Iran conflict and rising crude oil prices, which kept investors cautious. source
The surge in pharma stocks could indicate a shift in investor preference toward defensive sectors amid broader market volatility, particularly in light of geopolitical tensions and rising oil prices. Investors may closely monitor the pharmaceutical sector for further developments and potential earnings reports. Watch for upcoming earnings releases from key players in the sector, which could influence market sentiment further.